Sale!

MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to detect mutations in the MGAT2 gene. These mutations are responsible for a rare condition known as Congenital Disorder of Glycosylation Type IIa (CDG-IIa), which affects the body’s ability to properly attach sugar molecules to proteins (glycosylation). This disorder can lead to a wide range of symptoms, including developmental delay, intellectual disabilities, and abnormalities in various organs.

The test is conducted through a comprehensive analysis of the patient’s DNA, specifically targeting the MGAT2 gene to identify any genetic alterations. Given the complexity and precision of the testing process, the cost for this genetic test is set at 4400 AED. DNA Labs UAE utilizes advanced genomic technologies to ensure accurate and reliable results, providing essential information for the diagnosis, management, and potential treatment of this genetic condition. This test is crucial for families seeking answers to unexplained symptoms related to glycosylation disorders, offering a path towards better understanding and management of the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test

Test Name: MGAT2 Gene Glycosylation Disorder Type 2A Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for MGAT2 Gene Glycosylation Disorder Type 2A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MGAT2 Gene Glycosylation Disorder Type 2A.

Test Details

The MGAT2 gene encodes for an enzyme that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins. Glycosylation is important for the proper functioning of many proteins in the body, including those involved in cell signaling, immune system function, and tissue development.

Mutations in the MGAT2 gene can lead to a rare genetic disorder known as glycosylation disorder type 2A (also called MGAT2-CDG). This disorder is characterized by a range of symptoms that can vary in severity, including developmental delays, intellectual disability, seizures, abnormal facial features, and other physical abnormalities.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the MGAT2 gene that may be causing glycosylation disorder type 2A. This type of testing uses advanced DNA sequencing technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a patient’s genetic information.

NGS genetic testing for glycosylation disorder type 2A can help to confirm a diagnosis, guide treatment decisions, and provide important information for genetic counseling. It may also be used to identify other family members who may be at risk for the disorder.

Test Name MGAT2 Gene Glycosylation disorde type 2A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MGAT2 Gene Glycosylation disorde type 2A NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MGAT2 Gene Glycosylation disorde type 2A
Test Details

MGAT2 gene encodes for an enzyme that is involved in the process of glycosylation, which is the addition of sugar molecules to proteins. Glycosylation is important for the proper functioning of many proteins in the body, including those involved in cell signaling, immune system function, and tissue development.

Mutations in the MGAT2 gene can lead to a rare genetic disorder known as glycosylation disorder type 2A (also called MGAT2-CDG). This disorder is characterized by a range of symptoms that can vary in severity, including developmental delays, intellectual disability, seizures, abnormal facial features, and other physical abnormalities.

NGS (next-generation sequencing) genetic testing can be used to identify mutations in the MGAT2 gene that may be causing glycosylation disorder type 2A. This type of testing uses advanced DNA sequencing technology to analyze multiple genes at once, allowing for a more comprehensive analysis of a patient’s genetic information.

NGS genetic testing for glycosylation disorder type 2A can help to confirm a diagnosis, guide treatment decisions, and provide important information for genetic counseling. It may also be used to identify other family members who may be at risk for the disorder.